Session: Focus on BRCA and triple-negative breast  cancers

Speaker: Judy Garber, MD

This 90-minute concurrent session will provide information specifically for breast cancer survivors
with triple-negative cancer (er/pr negative and Her2neu negative) and or breast cancer survivors
who carry a BRCA mutation or whose cancer is hereditary. The session will provide information for
those who are newly diagnosed and those in active treatment for breast cancer. Dr. Garber will discuss:

• therapies that may specifically benefit breast cancer patients with triple-negative breast cancers
• therapies that may specifically benefit breast cancer patients with BRCA mutations
• clinical trials for new agents that may benefit survivors with triple-negative breast cancers
• clinical trials for new agents that may benefit breast cancer survivors with BRCA mutations
• survival, prognosis, and long-term quality-of-life issues specific to breast cancer survivors
• risk for second primary breast cancer and risk-management options for breast cancer survivors who
  have chosen lumpectomy and benefits and limitations of mastectomy vs. surveillance
• risk for ovarian cancer after breast cancer and risk-management options in breast cancer survivors
  
  

This session is appropriate for:

• breast cancer survivors with triple-negative breast cancer and/or a BRCA mutation
• relatives/loved ones/caretakers for people with breast cancer
• patient advocates, support group facilitators, and people who work with
  breast cancer survivors
• health care providers who treat breast cancer survivors
• social workers/mental health care professionals who treat people with breast cancer

Close Window